A

AIM

AIM

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
60%Neutral
Buy/Sell Ratio100% buys
BearishBullish
AIM Live QuoteReal-time
$0.14
$0.02(-15.00%)1M
Day Range$0.13 – $0.14
Open$0.13
Previous Close$0.13
Volume496.9K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$5.43M
P/E Ratio (TTM)24.5
Forward P/E2.0
EPS (TTM)$-3.09
Price to Book0.7
Dividend Yield0.65%
Beta (Volatility)1.31
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.14 (1%)
Low: $0.12High: $1.65
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$4.25-97.2% upside

Insider Buys

23

$215K

Insider Sales

1

$884

Total Volume

$216K

40 transactions

Net Activity

+$214K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys16 sells

$579.18B total

E
2

Equels Thomas K

CEO, Pres

18 buys0 sells

$142K total

K
3

Kellner Ted D

Dir

1 buys0 sells

$50K total

A
4

Appelrouth Stewart

Dir

2 buys0 sells

$18K total

M
5

Mitchell William M

Dir

1 buys1 sells

$6K total

Trading History
AIM insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 11, 2026

1 weeks ago

Equels Thomas K

CEO, Pres

CEO
Buy35.0K$0.15$5K

Oct 23, 2026

3 weeks ago

Equels Thomas K

CEO, Pres

CEO
Buy31.7K$0.16$5K

Oct 22, 2026

3 weeks ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell158.1K$31250.00$4.94B

Oct 22, 2026

3 weeks ago

Equels Thomas K

CEO, Pres

CEO
Buy31.3K$0.16$5K

Sep 17, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell126.8K$24000.00$3.04B

Sep 17, 2026

2 months ago

Equels Thomas K

CEO, Pres

CEO
Buy24.0K$0.21$5K

Sep 16, 2026

2 months ago

Equels Thomas K

CEO, Pres

CEO
Buy11.0K$0.21$2K

Sep 16, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell102.8K$11000.00$1.13B

Sep 15, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell91.8K$22000.00$2.02B

Sep 15, 2026

2 months ago

Equels Thomas K

CEO, Pres

CEO
Buy22.0K$0.22$5K

Sep 14, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell69.8K$5900.00$411.95M

Sep 14, 2026

2 months ago

Equels Thomas K

CEO, Pres

CEO
Buy5.9K$0.22$1K

Jun 13, 2025

17 months ago

Equels Thomas K

CEO, Pres

CEO
Buy107$7.70$824

Jun 13, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell38.9K$107.00$4.16M

Jun 12, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell38.7K$103.00$3.98M

Jun 12, 2025

17 months ago

Equels Thomas K

CEO, Pres

CEO
Buy103$8.70$896

Apr 11, 2025

19 months ago

Kellner Ted D

Dir

Director
Buy1.97M$0.03$50K

Apr 11, 2025

19 months ago

Mitchell William M

Dir

Director
Buy196.9K$0.03$5K

Apr 11, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell522.1K$196851.00$102.78B

Apr 11, 2025

19 months ago

Equels Thomas K

CEO, Pres

CEO
Buy1.97M$0.03$50K

Apr 4, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.90M$41000.00$77.86B

Apr 4, 2025

19 months ago

Equels Thomas K

CEO, Pres

CEO
Buy41.0K$0.06$3K

Apr 4, 2025

19 months ago

Rodino Peter W III

COO, Secretary, Gen. Counsel

COO
Buy500$0.09$44

Mar 5, 2025

20 months ago

Equels Thomas K

CEO, Pres

CEO
Buy50.0K$0.13$7K

Mar 5, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.86M$50000.00$92.90B

Mar 4, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.81M$44000.00$79.55B

Mar 4, 2025

20 months ago

Equels Thomas K

CEO, Pres

CEO
Buy44.0K$0.12$5K

Mar 4, 2025

20 months ago

Equels Thomas K

CEO, Pres

CEO
Buy83.3K$0.12$10K

Nov 21, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.66M$20000.00$33.16B

Nov 21, 2024

24 months ago

Equels Thomas K

CEO, Pres

CEO
Buy20.0K$0.21$4K

Dec 19, 2024

23 months ago

Mitchell William M

Dir

Director
Sell4.6K$0.19$884

Dec 19, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell118.9K$-4580.00$0

Dec 18, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.68M$22727.00$38.20B

Dec 18, 2024

23 months ago

Equels Thomas K

CEO, Pres

CEO
Buy22.7K$0.21$5K

Dec 2, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell355.5K$11112.00$3.95B

Dec 2, 2024

23 months ago

Appelrouth Stewart

Dir

Director
Buy11.1K$0.21$2K

Nov 20, 2024

24 months ago

Equels Thomas K

CEO, Pres

CEO
Buy85.0K$0.20$17K

Nov 20, 2024

24 months ago

Appelrouth Stewart

Dir

Director
Buy82.0K$0.19$16K

Nov 20, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.64M$85000.00$139.23B

Nov 20, 2024

24 months ago

Equels Thomas K

CEO, Pres

CEO
Buy60.1K$0.18$11K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
AIM Buy Conviction100%
Industry Rank#555 of 570
Volume Contribution0.0%
Total Industry Activity$15.24B

AIM has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. AIM ranks #555 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for AIM

Over the last 90 days, corporate insiders at AIM (AIM) engaged in a total of 40 transactions reported via SEC Form 4 filings. Among these, 23 were open-market purchases and 1 were sales. The total volume of insider trading reached $216K.

The net insider activity for AIM shows a net buying bias of $214K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.64M shares valued at $139.23B on Nov 20, 2024.

Live Market News & Developments
Aggregated real-time headlines for AIM (AIM)
6 updates

REG - AIM - Schedule One - SecondPass Research plc

TradingView12h ago

An Aim stock recovery that’s kicked into gear

Investors' Chronicle6h ago

AIM ImmunoTech Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Yahoo Finance6h ago

AIM ImmunoTech Inc. (AIM) Stock Price, News, Quote & History

Yahoo! Finance Canada4d ago

AIM ImmunoTech’s shareholder meeting adjourned when proxies covered about 32.5% of voting shares.

Stock Titan6h ago

Aim’s new rules put London back in the running for growth companies

FT Adviser2h ago

FAQs About AIM Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for AIM.

Based on SEC Form 4 disclosures, the Insider Confidence Score for AIM is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 23 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for AIM is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.